Prandin

Product manufactured by Novo Nordisk

Application Nr Approved Date Route Status External Links
NDA020741 1997-12-22 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Prandin Is Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. Limitation Of Use: Prandin Should Not Be Used In Patients With Type 1 Diabetes Mellitus Or For The Treatment Of Diabetic Ketoacidosis. Prandin Is A Glinide Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus (1) Limitation Of Use: Not For Treatment Of Type 1 Diabetes Mellitus Or Diabetic Ketoacidosis (1)

All Formulated Excipients (7 Total)

Name Structure Kind Function Status
1. Calcium Phosphate, Dibasic, Anhydrous CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS Molecular
2. Cellulose, Microcrystalline CELLULOSE, MICROCRYSTALLINE Unresolved
3. Starch, Corn STARCH, CORN Unresolved
4. Polacrilin Potassium POLACRILIN POTASSIUM Unresolved
5. Povidones POVIDONES Unresolved
6. Magnesium Stearate MAGNESIUM STEARATE Molecular AF-Antifoaming (or defoaming) agent , MISC-Miscellaneous REG-Food additives for which a petition has been filed and a regulation issued.
7. Meglumine MEGLUMINE Molecular

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Repaglinide REPAGLINIDE ZINC3798537

Comments